1. People's Republic of China Stocks

  2. •

    Technology

  3. •

    Software - Application
SPO Global Inc.

SPO Global Inc.

SPOM
SPO Global Inc.US flagOther OTC
0.00
USD
- -
- -
69,292.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
TTM
Revenue per Share
42,000
2,144.54
3,844.72
4,751.42
2,239.45
- -
135.4
11.92
141.7
135.51
7.89
6.27
0.46
0.18
Basic EPS, GAAP
-634,000
-2,394.83
-5,137.68
-1,521.82
-2,598.21
-364.12
-1,533.15
-957.69
-398.21
-166.46
-3.68
-6.46
-60.92
-8.53
Free Cash Flow per Basic Share
-122,250
-1,460.63
-543.48
-628.08
-982.95
100.76
-704.51
-215.73
-150.67
-73.85
-15.09
0.12
-1.03
-0.1
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-862,000
-6,951.82
-11,238.1
-11,800.76
-12,667.21
-12,274.05
-12,820.87
-11,771.75
-9,404.48
-5,271.75
-8.59
-44.09
-10.34
-11.31
Tangible Book Value per Share
-193,500
-1,539.37
-933.75
-506.64
-1,107.95
-1,279.39
-1,493.65
-1,477.35
-1,167.26
-648.06
-7.74
-45.23
-10.13
-1.44
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Sales/Revenue/Turnover
- -
2
4
5
3
- -
- -
- -
- -
1
- -
- -
- -
- -
Operating Margin (%)
1,353.57
77.86
17.8
15.22
-88.44
- -
-1,009.9
-8,555
-217.09
-64.75
-40.84
-95.32
-155.19
-52.08
Depreciation Expense
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-2
-5
-2
-3
- -
-2
-2
-1
-1
- -
- -
-15
-13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,509.52
-111.67
-133.63
-32.03
-116.02
- -
-1,132.29
-8,035
-281.01
-122.84
-46.58
-102.92
-13,117.81
-4,835.13
Working Capital
-1
-1
- -
-1
-1
-2
-2
-2
-2
-2
- -
-2
-2
-2
LT Debt
- -
- -
1
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
Total Equity
-1
-1
-1
-1
-1
-2
-2
-2
-3
-3
- -
-2
-3
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,838.19
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'16
Mar'17
Jun'17
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
3
3
Market Capitalization
74,869,500
210,634,333
151,102,850

Working Capital

FRC

•

in mil. unless spec.
Dec'16
Mar'17
Jun'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
- -
- -
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
61.46%
86.71%
15.59%
Free Cash Flow
-543.74%
-902.99%
-4,531.1%
Net Income, GAAP
498.07%
940.85%
4,767.31%
Sales/Revenue/Turnover
- -
288.41%
-61.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Fengyou Lu
Full Time Employees
7
Sector
Technology
Industry
Software - Application
Address
27/F,Block A Jinan People's Republic of China
IPO Date
Dec 16, 1999
CIK
0000716778
Website
gerpanghealthcare.com
Similar Companies
Japan PropTech Co.,Ltd. (4054.T)
SNP Schneider-Neureither & Partner SE (0NJB.L)
Danavation Technologies Corp. (DVNCF)
BMP AI Technologies, Inc. (BMPA)
Latch, Inc. (LTCHW)
Esker S.A. (ALESK.PA)
Business
SPO Global Inc. (SPOM) operates as a holding company with a primary focus on bio-pharmaceutical research and development; development and sales of medical informatization software; introduction of medical high-tech products; and production and sales of medical quality supplies, dietary supplements, and medicines, as well as agency and sales of medical equipment supplies. The company, headquartered in Jinan, China, at 27/F, Block A, primarily serves healthcare institutions, clinics, and hospitals in Shandong Province and surrounding regions through subsidiaries including Gerpang Healthcare Group and previously associated entities in traditional Chinese medicine devices. Core products encompass low-frequency therapeutic instruments for nerve repair and rehabilitation; intelligent Chinese medicine decocting machines that enhance extraction efficiency by 2-60 times using ultrasonic and low-temperature methods; and electrotherapy devices employing pulse currents below 1000Hz aligned with human bioelectric fields. In recent strategic shifts within the last two years, SPO Global divested its medical business amid Covid-19 challenges and completed a merger with Shandong Fangyuan Huizhong Intelligent Equipment Co., Ltd. (SFHI), pivoting toward food machinery including corn processing equipment; secured a $1.8 million contract from Raohe County Rural Revitalization Bureau for waxy corn projects; and formed partnerships such as with Cinuo Traditional Chinese Medicine Group and Fuyutang Franchises for medical terminal services. Previously known through its 2020 reverse merger acquisition by Gerpang Healthcare Group for $4.3 million, the company, led by CEO Fengyou Lu, maintains minimal current operations with eight employees while targeting expansions in Shandong, Qingdao, and Inner Mongolia.

Company News

APIChat